In our study, whether the serum ANGPTL4 decrease after ESCC surgery is due to tumor load reduction, or its raised level in a certain period be related to tumor recurrence or progression should be validated by long-term follow-up data in the future. The gene discussed is ANGPTL4; the disease is neoplasm.